FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W170744941> ?p ?o ?g. }

• W170744941 abstract "A variety of options, including surgery, radiation, chemotherapy, and biopharmaceuticals, or a combination of these therapies, have been developed and are commonly used for the treatment of cancer. However, these treatments often result in undesirable side effects for the patient and may not always be efficacious (1-3). As a result, the use of gene therapy as an alternative therapy for cancer has been developed and attempted by several investigators (4, 5). The adenovirus (Ad) is the most common vehicle used for the gene therapy of cancer, both as a vector and as an oncolytic agent (4, 5). The Ad is a non-enveloped DNA virus that binds to the Coxsackie-Ad receptor (CAR) on cells and has been studied for more than half a century. After binding to CAR, the virus interacts with the host cell integrins (which serve as secondary receptors) and is internalized by receptor-mediated endocytosis (6). A detailed description of Ad structure, gene composition, and biology is available elsewhere (7). Ad is one of the best-characterized viruses and, depending on the infecting serotype, is known to cause several different illnesses such as conjunctivitis, gastroenteritis, the common cold, and other respiratory ailments in humans (8, 9). There are ~50 serotypes of Ad, and among these Ad2 and Ad5 are the serotypes most commonly used for gene therapy. This is because Ad can be easily engineered to target a specific ailment such as cancer, can be made replication-deficient, does not integrate into the mammalian genome, can accommodate large transgenes, and can be modified to have a reduced immunological responses in mammals (10).To make recombinant Ad suitable for use as a gene therapy vector, several strategies are used by investigators in the field (11). A common approach to generate an Ad vector is by substituting a viral gene(s) with the gene(s) of interest (11). For selective infection of cancerous tumors, conditionally replicating Ads (CRAds) have been generated that replicate only in the neoplastic cells and locally amplify the virus, which ultimately results in lysis of the host cell (thus the virus is oncolytic) (12). The lack of replication in normal tissue restricts the infection of CRAds to the cancerous cells, and the CRAds would replicate only until the cancerous cells are depleted. Other advantages of using CRAds for cancer therapy are discussed in detail by Kanerva and Hemminki (12). Although CRAds are being used in several clinical trials in the United States, still little is known regarding their replication, spreading ability, persistence, and interaction with the host system (13). According to Ono et al., this is probably because a non-invasive monitoring system was not available to investigate these CRAd parameters (13). Ono et al. envisioned that CRAds could probably be studied in an in vivo setting if the vector could be monitored with a fluorescent reporter gene (13).This chapter details the development and in vitro and in vivo evaluation of a CRAd vector bearing the enhanced green fluorescent protein (EGFP) as the reporter gene (13)." @default.
• W170744941 created "2016-06-24" @default.
• W170744941 creator A5077155083 @default.
• W170744941 date "2008-01-02" @default.
• W170744941 modified "2023-09-27" @default.
• W170744941 title "Recombinant adenovirus with enhanced green fluorescent protein" @default.
• W170744941 cites W1965295123 @default.
• W170744941 cites W1973331890 @default.
• W170744941 cites W1988568788 @default.
• W170744941 cites W1990967992 @default.
• W170744941 cites W2003880226 @default.
• W170744941 cites W2005860058 @default.
• W170744941 cites W2038802889 @default.
• W170744941 cites W2066475295 @default.
• W170744941 cites W2116071714 @default.
• W170744941 cites W2145238190 @default.
• W170744941 cites W2146032890 @default.
• W170744941 cites W2183650544 @default.
• W170744941 cites W23246608 @default.
• W170744941 hasPublicationYear "2008" @default.
• W170744941 type Work @default.
• W170744941 sameAs 170744941 @default.
• W170744941 citedByCount "0" @default.
• W170744941 crossrefType "journal-article" @default.
• W170744941 hasAuthorship W170744941A5077155083 @default.
• W170744941 hasConcept C104317684 @default.
• W170744941 hasConcept C111599444 @default.
• W170744941 hasConcept C121608353 @default.
• W170744941 hasConcept C135983454 @default.
• W170744941 hasConcept C159047783 @default.
• W170744941 hasConcept C170493617 @default.
• W170744941 hasConcept C2522874641 @default.
• W170744941 hasConcept C28005876 @default.
• W170744941 hasConcept C40767141 @default.
• W170744941 hasConcept C54355233 @default.
• W170744941 hasConcept C70721500 @default.
• W170744941 hasConcept C71924100 @default.
• W170744941 hasConcept C82210918 @default.
• W170744941 hasConcept C86803240 @default.
• W170744941 hasConcept C92087593 @default.
• W170744941 hasConceptScore W170744941C104317684 @default.
• W170744941 hasConceptScore W170744941C111599444 @default.
• W170744941 hasConceptScore W170744941C121608353 @default.
• W170744941 hasConceptScore W170744941C135983454 @default.
• W170744941 hasConceptScore W170744941C159047783 @default.
• W170744941 hasConceptScore W170744941C170493617 @default.
• W170744941 hasConceptScore W170744941C2522874641 @default.
• W170744941 hasConceptScore W170744941C28005876 @default.
• W170744941 hasConceptScore W170744941C40767141 @default.
• W170744941 hasConceptScore W170744941C54355233 @default.
• W170744941 hasConceptScore W170744941C70721500 @default.
• W170744941 hasConceptScore W170744941C71924100 @default.
• W170744941 hasConceptScore W170744941C82210918 @default.
• W170744941 hasConceptScore W170744941C86803240 @default.
• W170744941 hasConceptScore W170744941C92087593 @default.
• W170744941 hasLocation W1707449411 @default.
• W170744941 hasOpenAccess W170744941 @default.
• W170744941 hasPrimaryLocation W1707449411 @default.
• W170744941 hasRelatedWork W109178030 @default.
• W170744941 hasRelatedWork W1528891054 @default.
• W170744941 hasRelatedWork W1536240574 @default.
• W170744941 hasRelatedWork W1982712041 @default.
• W170744941 hasRelatedWork W1993812884 @default.
• W170744941 hasRelatedWork W2001989483 @default.
• W170744941 hasRelatedWork W2008247134 @default.
• W170744941 hasRelatedWork W2075997360 @default.
• W170744941 hasRelatedWork W2084875579 @default.
• W170744941 hasRelatedWork W2088033621 @default.
• W170744941 hasRelatedWork W2110779133 @default.
• W170744941 hasRelatedWork W2113692842 @default.
• W170744941 hasRelatedWork W2348512129 @default.
• W170744941 hasRelatedWork W2483010734 @default.
• W170744941 hasRelatedWork W2665973600 @default.
• W170744941 hasRelatedWork W2749102943 @default.
• W170744941 hasRelatedWork W3109415474 @default.
• W170744941 hasRelatedWork W32938433 @default.
• W170744941 hasRelatedWork W1506198548 @default.
• W170744941 hasRelatedWork W2399776865 @default.
• W170744941 isParatext "false" @default.
• W170744941 isRetracted "false" @default.
• W170744941 magId "170744941" @default.
• W170744941 workType "article" @default.